Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07377175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 29, 2026 (before its estimated February 13, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
A Two-Phase, Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 for Injection Following Single or Multiple Doses in Healthy Subjects
Trial Details
NCT Number NCT07377175
Lead Sponsor China National Biotec Group Company Limited
Collaborators: Beijing Institute of Biological Products Co Ltd., Shulan (Hangzhou) Hospital
Conditions
(from sponsor)		 Smallpox, Cowpox, Monkeypox, Poxvirus Infection
Related terms Cowpox, Mpox, Monkeypox, Poxviridae Infections, Smallpox
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov